Want to see HCA full AI Analyst Report?
Adjusted EBITDA by Segment
Highlights profitability across different business units, providing insight into which segments drive earnings and where operational efficiencies or challenges lie.The operating groups delivered steady multi‑year EBITDA expansion (with typical Q4 strength), but the recent sequential pullback into early 2026 and a deeper, more volatile Corporate & Other drag show margins are under strain. Management attributes near‑term weakness to a concentrated payer‑mix shock from exchange disenrollment (a material EBITDA hit in Q2) partially offset by Medicaid supplemental payments; the company is leaning on cost‑resiliency programs and buybacks, so future upside depends on policy stabilization and successful execution of those savings initiatives.
Date | Corporate and Other | National Group | American Group | Atlantic Group |
|---|---|---|---|---|
Jun 30, 2026 | $353.00M | $1.18B | $1.37B | $1.83B |
Mar 31, 2026 | -$309.00M | $1.26B | $1.41B | $1.44B |
Dec 31, 2025 | -$447.00M | $1.35B | $1.72B | $1.49B |
Sep 30, 2025 | -$397.00M | $1.35B | $1.58B | $1.34B |
Jun 30, 2025 | -$352.00M | $1.27B | $1.58B | $1.35B |
Mar 31, 2025 | -$279.00M | $1.13B | $1.42B | $1.46B |
Dec 31, 2024 | -$287.00M | $1.17B | $1.62B | $1.22B |
Sep 30, 2024 | -$352.00M | $1.09B | $1.38B | $1.15B |
Jun 30, 2024 | -$288.00M | $1.10B | $1.42B | $1.31B |
Mar 31, 2024 | -$324.00M | $1.07B | $1.32B | $1.29B |